Company news
Cheng Du Sheng Nuo Biotec Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
2025 Semi-annual Report
August 14, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Ganirelix Injection
July 22, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Exenatide Injection
June 30, 2025
Announcement on Voluntary Disclosure of 2025 Semi-annual Earnings Preannouncement
June 19, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 8, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Report for Q1 2025
April 24, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2025
March 30, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Results of Share Reduction by Shareholders with Over 5% Shares
December 26, 2024
Announcement on the Company and Actual Controllers Providing Guarantee for the Wholly-owned Subsidiary's Application for Bank Comprehensive Credit Line
December 10, 2024
Indicative Announcement on Change in Equity of Shareholders Holding More than 5% of Shares
October 31, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 29, 2024
Announcement on the Resolution of the 22nd Meeting of the 4th Board of Supervisors
October 28, 2024
Announcement on Voluntary Disclosure of Performance Forecast in Q1-Q3 2024
October 9, 2024
Announcement on Progress of Controlling Shareholder's Plan for Negotiated Transfer of Some Shares
September 30, 2024
Announcement on Wholly-owned Subsidiary Singing Major Daily Operation Contracts
September 17, 2024
Announcement on Voluntary Disclosure of Signing Overseas "Strategic Cooperation Agreement"
September 6, 2024
Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5%
September 3, 2024
Indicative Announcement on Controlling Shareholder's Intention to Transfer Partial Equity of the Company by Agreement and Change in Equity
August 27, 2024
Announcement on Convening 2024 Semi-annual Performance Meeting
August 1, 2024
Announcement on Canceling Some Restricted Shares Granted and Not Yet Vested in 2023 Restricted Shares Incentive Plan
July 30, 2024